Comment
. 2005 Nov 24;353(21):2304-5; author reply 2304-5.
doi: 10.1056/NEJM200511243532122.
Case 24-2005: a woman with estrogen-receptor-positive breast cancer
- PMID: 16306534
- DOI: 10.1056/NEJM200511243532122
Item in Clipboard
Comment
Case 24-2005: a woman with estrogen-receptor-positive breast cancer
N Engl J Med.
.
No abstract available
Comment on
-
Case records of the Massachusetts General Hospital. Case 24-2005. A 58-year-old woman with early-stage estrogen-receptor-positive breast cancer.N Engl J Med. 2005 Aug 11;353(6):617-22. doi: 10.1056/NEJMcpc059018. N Engl J Med. 2005. PMID: 16093471 No abstract available.
Similar articles
-
Letrozole or tamoxifen in early breast cancer.N Engl J Med. 2006 Apr 6;354(14):1528-30; author reply 1528-30. N Engl J Med. 2006. PMID: 16602148 No abstract available.
-
Tamoxifen vs the aromatase inhibitors: news from San Antonio, 2001.Cancer Control. 2001 Nov-Dec;8(6):478-9. doi: 10.1177/107327480100800601. Cancer Control. 2001. PMID: 11807416 No abstract available.
-
[Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer. The example of the MA-17 study].Suppl Tumori. 2004 Jul-Aug;3(4):S25-6. Suppl Tumori. 2004. PMID: 15206205 Clinical Trial. Italian. No abstract available.
-
Anastrozole.Drugs Today (Barc). 2005 Apr;41(4):227-39. doi: 10.1358/dot.2005.41.4.908563. Drugs Today (Barc). 2005. PMID: 16034487 Review.
-
Changes in endocrine therapy: anastrozole and advanced breast cancer in postmenopausal women.Am J Hosp Palliat Care. 2004 Nov-Dec;21(6):457-65. doi: 10.1177/104990910402100612. Am J Hosp Palliat Care. 2004. PMID: 15612238 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
